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Abnormalities in vaginal epithelium, the
first line of defense against pathogens,
are associated with sexually transmitted
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show that CD271+Axin2+ basal cells are
vaginal stem cells that are responsible for
epithelial homeostasis and regeneration,
providing fundamental insights into the
maintenance of this epithelial barrier.
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The intact vaginal epithelium is essential for women’s
reproductive health and provides protection against
HIV and sexually transmitted infections. How this
epithelium maintains itself remains poorly under-
stood. Here, we used single-cell RNA sequencing
(RNA-seq) to define the diverse cell populations in
the vaginal epithelium. We show that vaginal epithe-
lial cell proliferation is limited to the basal compart-
ment without any obvious label-retaining cells.
Furthermore, we developed vaginal organoids and
show that the basal cells have increased organoid
forming efficiency. Importantly, Axin2 marks a self-
renewing subpopulation of basal cells that gives
rise to differentiated cells over time. These cells are
ovariectomy-resistant stem cells as they proliferate
even in the absence of hormones. Upon hormone
supplementation, these cells expand and reconsti-
tute the entire vaginal epithelium. Wnt/b-catenin is
essential for the proliferation and differentiation of
vaginal stem cells. Together, these data define het-
erogeneity in vaginal epithelium and identify vaginal
epithelial stem cells.INTRODUCTION
Vaginal epithelium (VE) is a keratinized stratified squamous
epithelium consisting of three layers: basal layer, suprabasal
layer, and apical cornified layer (Bragulla and Homberger,
2009). The VE lining is highly sensitive to modulation in estrogen
(E2) levels (Gardner, 1959) and plays a vital role in various repro-
ductive processes, presenting the first line of defense against the
pathogenic invasion in lower reproductive tract (Lee et al., 2016).
Experimental or age-related decline in E2 levels in mice and hu-
mans leads to regression of VE, which is reversed upon the
external supplementation of E2 (Edgren, 1959). This exceptional
regenerative capacity of VE suggests the existence of a popula-Cell R
This is an open access article undtion of epithelial stem/progenitor cells. However, the identity and
location of such cells is currently unknown.
Wnt signaling is an important regulator of various stages of fe-
male reproductive tract development and is a known master
controller of adult stem cell maintenance in many organ systems
(Kobayashi and Behringer, 2003; Nusse, 2008). Various studies
in human patients and mouse models have established that
deregulated Wnt signaling causes developmental defects and
diseases of reproductive tract organs (Ghosh et al., 2017;
Goad et al., 2017; Tanwar et al., 2010). Currently, very little is
known about the role of Wnt signaling in VE homeostasis.
In this study, using genetic cell lineage tracing, vaginal orga-
noid culture, targeted gene deletion, and single-cell sequencing
approaches, we revealed a unique population of VE stem cells
and provided evidence that canonical Wnt/b-catenin signaling
is required for the proliferation and differentiation of these stem
cells.
RESULTS
Analysis of Vaginal Epithelial Cells Using Single-Cell
Sequencing
To understand the overall diversity of cell types in VE, we per-
formed unbiased single-cell RNA sequencing (scRNA-seq) anal-
ysis on mouse VE cells from 5 mice in duplicate. A total of 4,940
cells, of the combined duplicates, that passed QC filtering were
clustered into six cell clusters using the k-means method and
visualized using t-Distributed Stochastic Neighbor Embedding
(tSNE) projection (clusters 0–5; Figures 1A and 1B; Table S1). Dif-
ferential gene expression and canonical pathway analysis re-
vealed that cluster 0 is enriched for the signaling pathways
(Wnt, Integrin, and Death receptor signaling) that are involved
in the regulation of various other epithelial stem/progenitor cells
and also expresses some of the known stem/progenitor cell
markers (Col17a1: collagen type XVII alpha 1 and Igfbp2: insu-
lin-like growth factor binding protein 2) of other organ systems
(Plasschaert et al., 2018; Tanimura et al., 2011) (Figures 1A–
1C). Cluster 1 represented a population of proliferating cells
(Ki67, Top2a, and Birc5) and showed upregulation of signaling
pathways involved in mitosis and DNA replication (Figures 1B–
1D). Clusters 2 and 3 represented cells in the state of transitioneports 30, 1463–1477, February 4, 2020 ª 2020 The Authors. 1463
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Figure 1. scRNA-Seq Shows Heterogeneity in VE
(A) tSNE plot of cell groups defined by k-means clustering analysis in mouse vaginal epithelium (VE).
(B) Dot plot shows the expression of top differential genes and their level of expression in different clusters identified.
(C) IPA analysis showing the upregulation of different canonical pathways in relation to the clusters.
(D) tSNE plot showing cell groups in each cell-cycle phase per cluster.
(E–I) tSNE plot showing expression of Tp63 (E), K17 (F), K14 (G), K5 (H), and a basal cell signature (I).
(J) Violin plots showing Tp63, K14, K5, and K17 expression in each cell cluster.
(K and L) Immunostaining for Tp63 (K) and K17 (L) in mouse VE.
(M–Q) tSNE plots showing expression of K1 (M), K10 (N), a suprabasal signature (O), Esr1 (P), and Pgr (Q) in different cell clusters.
(R–X) Immunostaining of vaginae for Ngfr/Cd271 (R and S) corresponding to cluster 0, Ki67 (T) and Birc5 (U) corresponding to cluster 1, Ifitm3 (V) corresponding to
cluster 3, Fabp5 (W) corresponding to cluster 4, and K1 (X) corresponding to cluster 5. The dotted line demarcates epithelium from adjoining stroma.
Arrows and asterisk in (C) point to stem/progenitor cell-related pathways and cell-cycle-associated pathways, respectively. Arrows in (R–V) mark positive cells.
OVX, ovariectomized, L, lumen, S, stroma. Bar, 100 mm.
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and various stages of epithelial differentiation as suggested
by the expression of markers including K13 (keratin 13), Calml3
(calmodulin-like protein 3), K4, and Ifitm3 (interferon-inducible
transmembrane protein 3) (Figures 1B and 1C; Table S1). Finally,
clusters 4 and 5, expressing K1 and K10, represented terminally
differentiated cells (Figures 1A–1C).
Next, we examined the expression of some of the well-estab-
lished markers of basal (Tp63, K17, K14, and K5) and supra-
basal/cornified cells (K1 and K10) of adult VE (Gimenez-Conti
et al., 1994; Kurita et al., 2005). The basal cell markers were
broadly expressed in almost all of the cell clusters, marking
both proliferating and differentiating cells (Figures 1E–1J). Immu-
nostaining for Tp63 and K17 also confirmed that their expression
is present in both the basal and suprabasal layers and is not
limited to a specific basal layer (Figures 1K and 1L). Expression
of K1 and K10 validated that clusters 2, 4, and 5 consist of differ-
entiated cells (Figures 1M and 1N), which was further confirmed
by scoring for the gene signature of suprabasal cells (Figure 1O).
Consistent with the in situ expression of estrogen and progester-
one receptors (Esr1 and Pr) in mouse VE (Li et al., 2018; Mehta
et al., 2016), their expression was widely present in all clusters
(Figures 1P and 1Q). Using immunohistochemistry, we validated
the expression of some of these newly discovered markers rep-
resenting the different cell clusters to confirm whether they are
bona fide markers of specific subsets of VE cells. In both normal
and atrophied VE, Ngfr/Cd271 (nerve growth factor receptor), a
member of the death receptor signaling family and an estab-
lished marker of the lung stem cells (Lavrik et al., 2005; Rock
et al., 2009), was mainly expressed in a single layer of basal cells
located adjacent to stroma (Figures 1R and 1S). This single layer
of basal cells, along with cluster 1, also expressed Ki67 (Fig-
ure 1T). Birc5, a specific marker of the G2/M phase of the cell cy-
cle (Caldas et al., 2005), was also expressed by the same basal
layer, although the expression was limited to fewer cells
compared to Ki67 (Figure 1U). Given that the Ki67 expression
is maintained in post-mitotic cells that have already exited the
cell cycle (Pacal and Bremner, 2012; Sobecki et al., 2017), we
concluded that only a few cells in the basal layer are actively
proliferating, as marked by Birc5. Ifitm3, a known inhibitor of
Zika virus replication (Savidis et al., 2016), marked a unique sub-
set of suprabasal cells (Figure 1V), suggesting that these cells
might be involved in the antiviral defense of VE. Fab5 (fattyFigure 2. Conditional Inactivation of b-Catenin Leads to Defective Self
(A and B) Wnt4, Wnt7b, Wnt11, Dkk2, Dkk3, Sfrp1, Sfrp2, and Sfrp4 mRNA in pr
(C) In situ hybridization for Wnt4, Dkk2, Dkk3, and Sfrp2 in OVX and E2-treated
bacterial gene dihydrodipicolinate reductase (DapB) were positive and negative
(D) Expression of Wnt ligands in VE upon E2 treatment of OVX mice compared t
(E) Schematic depicting the regimen for induction of recombination in Ctnnb1fl/fl
(F) H&E staining of VE in Ctnnb1fl/fl mice at 14 weeks age (a) and Ctnnb1cko mice
(G and H) Quantification of vaginal epithelial thickness (G) (n = 3, p < 0.0001) and
(I) Co-immunostaining for b-catenin with Tp63 (a basal cell marker; a and b), K1 (a
terminal epithelial cell differentiation marker; e and f), Ki67 (a marker of cell prolifer
mice VE.
(J) Relative levels of Ctnnb1 (b-catenin), K1, and Flg in control and Ctnnb1cko mi
(K) Quantification of Ki67+ cells in control and Ctnnb1cko mice VE (n = 3, p < 0.00
(L) Schematic depicting VE specific b-catenin deletion and subsequent mass sp
(M) Heatmap depicts the protein expression pattern of various keratins and Flg i
Data represents mean ± SEM. OVX, ovariectomized, L, lumen. Bar, 100 mm.
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jority of the suprabasal cells but the expression was absent in the
single basal cell layer (Ngfr+ Ki67+) adjacent to the stroma (Fig-
ures 1W and 1X), implying their status as differentiating cells.
We further analyzed some of the markers of these different cell
clusters in the human protein atlas database and identified a
similar level of heterogeneity in human VE (Figures 1B and S1).
In summary, these data highlight the heterogeneity in the basal
and suprabasal layers of VE. We also discovered new bona
fide markers of different subpopulations of VE cells.
Mapping Wnt Signaling Changes in Normal and
Regenerated VE
Given that Wnt/b-catenin signaling was one of themost enriched
pathways in the VE cells (Figure 1C), we looked at the expression
of variousWnt pathwaymembers in mouse vagina includingWnt
ligands, secreted frizzled-related protein genes (Sfrp1–5), Dick-
kopf-related protein 1–4 (Dkk1–4), and WNT inhibitory factor 1
(Wif1) using RNA in situ hybridization. In young mice (Figure 2A),
Wnt4 and Wnt7b expression was present in both basal and
suprabasal layers, whereas Wnt11 expression was restricted
to suprabasal cells. In adulthood (Figure 2B), mice retained the
Wnt4 and Wnt11 expression pattern of young mice; however,
Wnt7b expression got mainly restricted to suprabasal layer. In
both young and adult vaginae (Figures 2A and 2B), Dkk2, a
known Wnt inhibitor, was expressed in stromal cells subjacent
to the basal layer, whereas Dkk3 and Sfrp1 were predominantly
expressed in basal cells but not in the suprabasal cells. The
expression of Sfrp2 and Sfrp4 was exclusive to the vaginal
stroma in both young and adult vaginae (Figures 2A and 2B).
E2 treatment alone is sufficient to cause the complete regener-
ation of atrophic VE in ovariectomized (OVX) mice (Miyagawa and
Iguchi, 2015). To determine whether E2 activates Wnt signaling
during VE regeneration, we assessed changes in the expression
levels of Wnt ligands and Wnt inhibitors/modulators in response
to E2 treatment, by performing in situ hybridization in atrophied
VE of OVX mice and E2-induced regenerated VE (Figure 2C). E2
treatment resulted in the upregulation of Wnt4 and Dkk2 expres-
sion in the regenerated VE compared to the vehicle-treated atro-
phied VE (Figure 2C), and the expression was similar to adult
cycling vaginae (Figure 2B). In contrast, Dkk3 and Sfrp2 expres-
sion was downregulated in E2-treated mice compared to the-renewal and Differentiation of Vaginal Epithelial Cells
e-pubertal (A) and adult (B) mice VE.
OVX VE. The housekeeping gene peptidylprolyl isomerase B (Ppib) and the
controls, respectively.
o vehicle-treated OVX control mice.
mice.
at 7 (b), 11 (c), and 14 (d) weeks age.
organ weight index (H) (n = 3, p = 0.008) in control and Ctnnb1cko mice.
stratified squamous epithelium differentiation marker; c and d), filaggrin (Flg; a
ation, g and h), and Ngfr (a marker of stem cells, i and j) in control andCtnnb1cko
ce (n = 3).
01).
ectrometry analysis.
dentified 1, 2, and 8 weeks after b-catenin deletion.
(legend on next page)
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controls (Figure 2C). For further confirmation of these findings, we
performed qPCRarrays to examine the expression of variousWnt
ligands (Figure 2D). Expectedly, the expression of several Wnt li-
gands (Wnt3a,Wnt4,Wnt5a,Wnt7b, andWnt10a) was increased
in E2-treated group compared to controls (Figure 2D). Collec-
tively, these data suggest that E2-mediated activation of Wnt
signaling is finely calibrated by the differential regulation of the
expression of various Wnt signaling pathway activators and
inhibitors.
Canonical Wnt/b-Catenin Signaling Is Essential for
Vaginal Epithelial Cell Proliferation and Differentiation
To investigate the role of Wnt signaling in VE, we developed a
mouse model in which b-catenin (Ctnnb1) is specifically ablated
in K14-expressing cells using a K14 promoter-driven inducible
Cre recombinase (K14CreERT2/Ctnnb1fl/fl; Ctnnb1fl/fl). Adminis-
tration of a low dose of tamoxifen (1 mg/mouse) for 5 consec-
utive days to Ctnnb1fl/fl mice resulted in the recombination of
flox Ctnnb1 alleles in the majority of K14+ cells (K14CreERT2/
Ctnnb1D/D; Ctnnb1cko) (Figure 2E). Histological examination re-
vealed a progressive decrease in VE thickness and the loss of
suprabasal layer but not the basal layer in mutants compared
to controls (Figure 2F). At 14 weeks of age (7 weeks post-
tamoxifen administration), mutant VE consisted of only basal
epithelium, which was 1–2 cell layers thick (Figures 2F and
2G). Compared to controls, mutant vaginal organ weight index
was also significantly reduced (Figures 2H). As expected,
b-catenin protein expression was absent in mutant but not in
control epithelium (Figure 2I). To precisely determine the role
of Wnt/b-catenin signaling in VE proliferation and differentia-
tion, we performed immunostaining for the markers specific
to different VE cell types. Tp63 was expressed by vaginal basal
cells in both control and mutant mice (Figures 2Ia and 2Ib). The
expression of K1 and filaggrin (Flg), known markers of differen-
tiated VE cells, was present in controls but not in mutants (Fig-
ures 2Ic–2If and 2J). Proliferating cells, as marked by Ki67,
were present in both controls and in mutants, albeit at a signif-
icantly reduced level in the mutant VE (Figures 2Ig, 2Ih, and 2K).
Ngfr was also expressed in both control and mutant vaginae
(Figures 2Ii and 2Ij). We also performed unbiased quantification
of various keratins in mutant VE at different chases post-
tamoxifen administration using mass spectrometry. Consistent
with our marker analysis, we found a reduction in the expres-
sion levels of keratins in the vaginal basal and suprabasal
epithelial layers (Figures 2L and 2M). Collectively, these data
suggest that canonical Wnt/b-catenin signaling is essential forFigure 3. Proliferating Cells Are Located in the Basal Compartment of
(A) H&E and Ki67 immunostaining of VE from normal cycling mice (a, d, and g), O
across different estrus-cycle stages (k–n). (g–i) represents high-magnification ima
Ki67+ cells. Quantification of Ki67+ cells in VE of mice from the indicated groups
(B) Schematic of the timeline of IdU administration and subsequent tissue collectio
and 3 days (h and i) post-initial labeling.
(C) Short-term sequential labeling regimen; CldU, IdU, and Tp63 co-staining (a
collected 24 h post-IdU treatment.
(D) Long-term sequential labeling regimen in OVX mice; CldU, IdU, and Tp63 co-
mice VE collected 24 h post-IdU treatment.
Data represents mean ± SEM. Arrows in (Ca and Cb) and (Da and Db) point towa
epithelium from the adjoining stroma. OVX, ovariectomized, L, lumen, S, stroma
1468 Cell Reports 30, 1463–1477, February 4, 2020the proliferation as well as the differentiation of vaginal basal
cells.
VESelf-renews duringRegeneration andNormal Growth
In adult mice, VE is a multilayered, stratified, and keratinized
epithelium (Figure 3Aa). Ovariectomy-induced E2 withdrawal re-
sulted in the atrophy of VE, which consisted of only 2–3 layers of
basal cells (Figure 3Ab). Interestingly, external supplementation
of E2 was sufficient to cause the complete regeneration of multi-
layered stratified squamous VE, which resembled VE of adult
cycling mice with intact ovaries (Figures 3Aa–3Ac). When we
looked at the expression of Ki67 in the VE of normal cycling
mice, atrophied epithelium of OVX mice and the regenerated
epithelium of E2-treated OVX mice, it was present mainly in
the basal layer adjacent to the basement membrane (Figures
3Ad–3Ai). E2 treatment, however, significantly increased the
proliferation index of basal cells in the regenerated epithelium
and reinstated it to control levels (Figures 3Ag–3Aj). Since the
basal cells proliferate even in absence of ovarian hormones in
OVX mice (Figures 3Ah and 3Aj), it seems plausible that E2 is
not required for their self-renewal and maintenance. However,
E2 is essential for the epithelial regeneration since it increases
the proliferation of basal cells (Figures 3Ai and 3Aj), the proge-
nies of which might subsequently differentiate into suprabasal
cells. In adult cycling mice, the proliferation was restricted to
the basal layer across all cycle stages (Figures 3Bk–3Bo). These
results suggest that mitotically active cells are limited to the
basal layer of VE that could be the possible site for vaginal
stem/progenitor cells.
Next, to define the proliferative compartment of VE, we used
an unbiased DNA analog-based technique. This well-estab-
lished approach has been used successfully to define the prolif-
erative compartments in various other organ systems (Teta et al.,
2007). Using the standard protocol (Tuttle et al., 2010), first, we
confirmed the specificity of the two different forms of anti-bro-
modeoxyuridine (BrdU) antisera in detecting the two thymidine
analogs, 5-chloro-2-deoxyuridine (CldU) and 5-iodo-2-deoxyur-
idine (IdU), and the ability of this methodology to detect a well-
established intestinal stem cell compartment (Figure S2). To
investigate whether VE harbors a label-retaining cell population,
we continuously administered ldU to adult cycling mice for
1 week (Figure 3Ba). Analysis of the VE immediately post-IdU
administration revealed the presence of IdU-labeled cells mainly
in the basal layer (Figures 3Bb and 3Bc), suggesting that the cells
had undergone replication during this labeling period. At subse-
quent chase points, there was a progressive dilution of the IdUMouse Vagina
VX mice (b, e, and h), E2-treated OVX mice (c, f, and i), and adult cycling mice
ges of insets in (d)–(f). E in (a)–(c) denotes the thickness of VE. Arrows denote
(j, n = 3, p = 0.0001) and across estrus-cycle stages (o) is shown.
n (a). Immunostaining for IdU in VE at 0 h (b and c), 24 h (d and e), 48 h (f and g),
and b); and quantification of CldU+, IdU+, and colabeled cells (c) in mice VE
staining (a and b); and quantification of CldU+, IdU+, and colabeled cells (c) in
rd the cells that are positive for all three markers. The dotted line demarcates
. Bar, 100 mm.
(legend on next page)
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label in the basal cells (Figures 3Bd–3Bi). By 3 days post-label-
ing, the IdU label had diluted to below the detection threshold
such that none of the basal cells were labeled (Figures 3Bh
and 3Bi). This suggested that the IdU-labeled basal cells had
undergone multiple rounds of cell division and that there are
no slow cycling cells residing in the VE basal compartment. Inter-
estingly, concomitant with the IdU-label dilution in the basal
layer, we observed the appearance of IdU-labeled cells in the
suprabasal layers (Figures 3Bd–3Bg). These IdU-labeled cells
in suprabasal layers correspond to the post-mitotic progenies
of labeled basal cells that had left the basal compartment and
committed to the differentiation into suprabasal cells. This is
consistent with our observation that Ki67+ proliferating cells
are also primarily present in the basal layer (Figure 3A).
To determinewhether proliferating cells in VE undergomultiple
rounds of cell division, we sequentially labeled adult mice with
CldU followed by IdU (Figures 3C and S2). Twenty-four hours
post-IdU administration, the cells that had undergone cell divi-
sion during the first round of labeling when CldU was given
had differentiated andmigrated toward the lumen, while the cells
that had undergone cell division during the second round of la-
beling when IdU was given were mainly confined to the basal
cell layers (Figures 3Ca–3Cc). Moreover, the cells that were
co-labeled with both CldU and IdU were mainly localized to the
basal compartment and were positive for a known basal cell
marker Tp63 (Figures 3Ca–3Cc and S2), suggesting that basal
cells have the ability to undergo multiple rounds of cell division.
Importantly, when we sequentially labeled OVX adult mice with
CldU followed IdU (Figure 3D), and analyzed the vaginae 24 h
post-IdU labeling, we detected IdU+, CldU+, as well as CldU-
IdU co-positive cells in the basal layer of the atrophied VE (Fig-
ures 3Da–3Dc), suggesting that the basal cells undergo multiple
rounds of cell division even in the absence of ovarian hormones.
In summary, these results confirmed that mitotically active prolif-
erating cells are present in the basal layer of VE.
Establishment and Characterization of Vaginal
Organoids
Organoid formation in other organ systems is associatedwith the
presence of adult stem cells (Clevers, 2016). Therefore, to estab-Figure 4. Establishment and Characterization of Mouse Vaginal Organ
(A) Timeline depicting organoid development from a single mouse vaginal epithe
accumulation of mucinous secretion respectively.
(B) Quantification of the distribution of organoid sizes over a period of 21 days in
(C) Quantification of the average organoid size at various days of culture.
(D and E) Representative images (Da and Db) and quantification (E) of the organ
(F) Organoid formation after estrogen treatment (n = 5 mice; p = 0.0371).
(G and H) Representative images of the organoids (Ga and Gb) and quantifica
epithelium and the basal epithelium (n = 3, p = 0.02).
(I) Histological analysis (a and b) and immunostaining for Tp63 (c and d), K5 (e and f
(J) Histological analysis and immunostaining for Tp63, filaggrin, and Ki67 of vagin
those developed from epithelial cells isolated from Ctnnb1fl/fl mice and cultured
(K and L) Quantification of organoid forming efficiency (K) and organoid size (L) in
(M and N) Quantification of filaggrin positive organoids (M) and the average numb
0.05, ****p < 0.0001).
(O Representative images and histology of organoids cultured in presence of the
(P and Q) Quantification of the organoid size (P) and organoid formation efficiency
0.05, ***p < 0.001, ****p < 0.0001).
Data represents mean ± SEM. Arrows mark differentiated cells. L, lumen, p, pas
1470 Cell Reports 30, 1463–1477, February 4, 2020lish the presence of stem/progenitor cells in vagina, we sought to
develop vaginal organoids. Briefly, VE was isolated and digested
enzymatically into a single-cell suspension of VE cells, which
were subsequently cultured in basement membrane matrix
extract (BME) supplemented with epidermal growth factor
(EGF), a TGF-br kinase inhibitor (transforming growth factor b re-
ceptor), and aROCK inhibitor (Rho-associated protein kinase). In
comparison to the complex culture conditions and media
composition used in the organoid culture of various other organs
(Kaushik et al., 2018), our relatively simple culture conditions
were sufficient for these single cells to develop into organoids
when cultured for 21 days (Figure 4A). Importantly, these vaginal
organoids developed from single cells and progressively grew
in size (Figures 4A–4C). By 7 days, a differentiated suprabasal
cell layer was formed in the center of the organoids (Figures
4A–4C, arrow). At 21 days of culture, the lumen was filled with
mucinous secretions (Figure 4A, asterisk), which is a natural
characteristic of the VE in vivo (Carson et al., 1998). A cardinal
feature of stem cell-derived organoids is their ability to propa-
gate in culture conditions for a long time (Clevers, 2016). Accord-
ingly, these vaginal organoids could also bemaintained for a long
time through serial passaging (Figures 4D and 4E). Expectedly,
treatment with E2 increased the growth of these organoids (Fig-
ure 4F). To determine whether the basal cells aremore efficient in
developing organoids, we cultured isolated VE cells from OVX
mice. We found that the organoid forming efficiency of basal
cells was significantly higher compared to the whole VE (Figures
4G and 4H).
Histological examination revealed that these vaginal organo-
ids comprising multilayered epithelial cells organized into basal
and suprabasal layers with a keratinized center, which is similar
to in vivomouse VE (Figures 4Ia and 4Ib). The expression pattern
of the known basal cell (Tp63 and K5) and suprabasal/kerati-
nized cell (Flg) markers was also comparable to in vivo vaginal
tissue (Figures 4Ic–4Ih). As expected, proliferating cells (Ki67+)
were mainly restricted to the basal layer in both the organoids
as well as mouse vagina (Figures 4Ii and 4Ij). Importantly, these
organoids survive freeze-thaw cycles such that they can be
frozen in liquid nitrogen and thawed for subsequent culturing
at later dates. In summary, we have established a simple andoids
lial cell. The arrow and asterisk in (A) indicate the formation of lumen and the
culture.
oid formation efficiency at indicated passages.
tion of the organoid formation efficiency (H) of cells isolated from the whole
), filaggrin (g and h), and Ki67 (i and j) of mouse vaginal organoids and in vivo VE.
al organoids cultured in presence of vehicle (control), IWP2, and 25%WRN or
in presence of tamoxifen (Ctnnb1cko).
indicated treatment groups (n = 5 mice, *p < 0.05, ***p < 0.001, ****p < 0.0001).
er of Ki67+ cells per organoid (N) in the indicated treatment groups (n = 5, *p <
indicated concentrations of WRN-conditoned medium.
(Q) at indicated concentrations of WRN-conditioned medium (n = 5 mice, *p <
sage. Bar, 100 mm.
(legend on next page)
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highly efficient method of developing vaginal organoids, which
closely mimic the mouse VE.
To investigate further the role of Wnt signaling in VE mainte-
nance, we examined the response of vaginal organoids to Wnt
signalingmodulation (Figure 4J). Treatment with IWP-2, a proven
small-molecule inhibitor of Wnt signaling (Chen et al., 2009),
decreased the number and size of organoids (Figures 4J–4L). A
similar phenotype was displayed by the organoids developed
from the VE cells isolated from Ctnnb1fl/fl mice and treated
in vitro with a low dose of tamoxifen to induce the ablation of
b-catenin (Figures 4J–4L). On the other hand, activation of Wnt
signaling by adding WRN (Wnt3a, Rspondin, and Noggin) condi-
tioned media to organoids significantly increased their number
but decreased their size as compared to the control organoids
(Figures 4J–4L). Histological and marker (Tp63 and Flg) analysis
revealed that Tp63+ basal cells were located at the periphery of
organoids in all the groups (Figure 4J). However, Flg+ differenti-
ated cells were only present in the control group and were rarely
seen in organoids from the other three groups (Figures 4J and
4M). Proliferating cells were present in the basal layer, but their
number was decreased in all the groups compared to controls
(Figures 4J and 4N). Since, in IWP2,Ctnnb1cko, andWRNgroups,
organoids were smaller in size as compared to the control group
and were missing the differentiated cell layers, quantifying the
percentage of total Ki67+ cells would overestimate the prolifera-
tion index of organoids in these groups, which is otherwise lower
than the control group. Therefore, we quantified the number of
Ki67+ cells per organoid rather than the percentage of Ki67+ cells.
Next, we assessed the impact of increasing Wnt signaling on the
organoid growth.We found thatwith aprogressive increase in the
WRNconditionedmediumconcentration, the organoid formation
efficiency significantly increased (Figures 4O–4Q). However, or-
ganoids cultured in highWnt (50%WRN) conditionswere smaller
in size and lacked a typical differentiated cell layer normally pre-
sent in the center of the vaginal organoids (Figures 4O and 4Q),
implying that hyperactive Wnt signaling impairs both the prolifer-
ation and differentiation of vaginal basal cells. In summary, these
results suggest that balanced Wnt signaling is essential for the
proliferation and differentiation of vaginal basal epithelium.
In Vivo Genetic Cell Lineage Tracing of K14+ Basal Cells
Given that the cell proliferation is limited to basal cells, which are
more efficient in forming organoids containing all VE cell typesFigure 5. Vaginal Basal Cells Contribute to Epithelial Renewal during N
(A) Schematic depicting label induction in K14CreERT2/lacZfl/+ mice.
(B and C) X-gal staining of K14CreERT2/lacZfl/+ mice vaginae (B) and quantification
4 weeks (g and h) post-induction (n = 3, *p < 0.05, ****p < 0.0001). Arrows indica
(D) Schematic depicting label induction in OVX K14CreERT2/lacZfl/+ mice.
(E) Xgal staining and immunostaining for Tp63 (a and b), filaggrin (c and d), and Ki
OVX K14CreERT2/lacZfl/+ mice.
(F) A tSNE plot of cell clusters defined by k-means clustering analysis in atrophie
(G) Dot plot showing the expression level of differential genes in each of the clus
(H–S) tSNE plots showing expression of Tp63 (H), K14 (I),K5 (J),K17 (K), a basal si
(R), and a stem cell signature (S).
(T and U) In situ hybridization for Axin2 mRNA in mouse vagina (T) and vaginal o
(V) Immunostaining for Ngfr in mouse vaginal organoids.
Data represents mean ± SEM. Dotted lines in (B) and (E) demarcate VE from the a
white (V) arrows point to Axin2+ andNgfr+ cells, respectively. OVX, ovariectomized
1472 Cell Reports 30, 1463–1477, February 4, 2020(Figures 3 and 4), next, we decided to trace the fate of K14+ basal
cells and determine their contribution to other cell lineages of VE.
For that, we performed genetic cell lineage tracing using
K14CreERT2/lacZfl/+ (K14lacZ) mice, in which K14Cre recombi-
nase-expressing cells and their descendants express lacZ upon
tamoxifen administration (Figures 5A–5C). Previous cell-fate
tracing studies have identified K14Cre-marked basal cells as
the stem cells of lung (Hong et al., 2004), bladder (Papafotiou
et al., 2016), and prostate (Ousset et al., 2012). Compared to
the widespread in situ expression of K14, K14Cre is expressed
in fewer cells, allowing for clonal analysis of marked cells, espe-
cially after a low dose of tamoxifen administration (Figures 1G,
5A, and 5B). Therefore, we labeled the K14+ cells of adult VE by
administering K14lacZ mice with a single dose of tamoxifen
(2mg/mouse) (Figure 5A). Forty-eight hours after the tamoxifen in-
jection, single cells at the base of the VE were marked with lacZ,
as is indicated by the blue labels in (Figure 5Ba, arrow). At subse-
quent chase points, these LacZ-labeledK14+ cells and their prog-
enies populated the entire VE, whichwas evident as parallel strips
of lacZ+ cells originating from the base and progressing through
the suprabasal layer toward the lumen (Figures 5B and 5C).
Expectedly, K14lacZ mice without tamoxifen exposure showed
no lacZ activity (Figure S3). These results suggest that K14+ basal
cells can self-renew and give rise to the suprabasal cells of VE.
To investigate whether basal cells are involved in VE regener-
ation, we traced the fate of labeled K14+ basal cells during
tamoxifen induced VE regeneration. For that, we OVX K14lacZ
females to induce atrophy of VE (Figure 5D). Expectedly, after
a rest period of 14 days necessary to get rid of the remaining
circulating ovarian hormones, the atrophied VE of these mice
comprised of a thin epithelial layer, which consisted mainly of
basal cells (Tp63+ and Flg–) (Figures 5Ea and 5Ec). Next, we in-
jected these OVX K14lacZ mice with a single dose of tamoxifen
(2 mg/mouse; Figure 5D), which serves two distinct functions in
this model system. First, it activates the K14Cre recombinase to
cause the recombination of flox lacZ alleles. Second, due to
its strong pro-estrogenic activity, it causes the regeneration of
VE, similar to what we observed after E2 supplementation (Fig-
ure 3B). Indeed, the atrophied VE of OVX K14lacZ mice
completely regenerated following the tamoxifen administration.
Importantly, the newly regenerated suprabasal layer was LacZ
labeled (Figures 5Eb, 5Ed, and 5Ef). Both Tp63+ and Flg+ cells
were present in the lacZ+ epithelial streaks, confirming theormal Growth and Regeneration
of labeling index (C) at 48 h (a and b), 1 week (c and d), 2 weeks (e and f), and
te bgal+ vaginal epithelial cells.
67 (e and f) in vaginae of vehicle (a, c, and e) and tamoxifen (b, d, and f)-treated
d VE of OVX mice.
ters identified.
gnature (L), K1 (M), K10 (N), a suprabasal signature (O), Axin2 (P),Ngfr (Q),Bmi1
rganoids (U).
djoining stroma. Dotted lines in (T) demarcate basal epithelium. Black (U) and
, L, lumen, S, stroma, TAM, tamoxifen. Bar, 100 mmunless otherwise indicated.
(legend on next page)
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presence of both basal and suprabasal/keratinized cells in the
regenerated epithelium (Figures 5Eb and 5Ed, arrow). Prolifer-
ating cells were present at the base of the lacZ+ epithelial
streaks, and, comparatively, very few proliferating cells were
present in the VE of OVX mice that were not administered with
tamoxifen (Figures 5Ee and 5Ef, arrow). This suggests that the
actively dividing basal cells drive the regeneration of VE.
Vaginal Basal Cell Heterogeneity and a Fraction of Cells
Marked by Stem Cell-Related Markers
To understand the basal cell heterogeneity and identify the
signaling pathways that are involved in the maintenance of these
cells, we performed scRNA-seq analysis of the OVX epithelium
similar to that shown in Figure 1 and compared it withWT epithe-
lium (Figures 5 and S4). A total of 3,723 cells that passed the QC
filter were analyzed (Figure 5F; Table S1). Using k-means
method these cells were categorized into 6 cell clusters (0–5),
whichwere visualized using tSNEprojection (Figure 5F). Interest-
ingly, marker expression of clusters 0, 1, and 2 was consistent
with that of basal cells (K14+, Tp63+, K5+, K17+, and positive
for a basal signature), as was expected from the OVX epithelium
(Figures 5G–5L). Furthermore, consistent with our observation in
the hormonally intact epithelium (Figure 1), the cells in these clus-
ters also expressed Col17a1, a known marker of skin stem cells
(Tanimura et al., 2011), and showed upregulation of Wnt/b-cate-
nin signaling (Figures 5G and S5). Cluster 3 expressed genes
involved in epithelial differentiation (Spink5 and K13) (Figures
5F and 5G). Expectedly, we did not observe any defined expres-
sion of knownmarkers of differentiated VE cells (K1+, K10+, and a
suprabasal signature) (Figures 5M-–5O). These data suggest
that OVX epithelial cells do not undergo the process of complete
differentiation due to lack of estrogen, which is essential for the
differentiation of this epithelium (Miyagawa and Iguchi, 2015),
although some of the cells are committed for early differentiation
as reflected by their expression of Spink5 and K13. Due to a low
cell number and a high percentage of mitochondrial genes and
the genes associated with immune system, we did not consider
clusters 4 and 5 for further analysis (Figures 5F and 5G). Given
the highly regenerative nature of OVX VE cells, next, we exam-
ined the expression of some of the known markers of stem/
progenitor cells of various other organ systems (Table S1). Inter-Figure 6. Axin2 Marks Self-renewing Basal Cells that Can Regenerate
(A) Schematic depicting the timeline of doxycycline administration for single-cell
and tissue sections at 48 h (a and b; arrowheads mark bgal+ cells), 1 week (c an
(B) Quantification of labeling index at indicated time points (n = 3, *p < 0.05, ****p
(C) Schematic depicting the timeline of doxycycline administration for labeling at
(a and b), 5 months (c and d), 10 months (e and f) post-induction.
(D) Quantification of labeling index at indicated time points (n = 3).
(E) Schematic depicting the timeline of doxycycline administration to OVX mice
tissue collection. X-gal staining of thick slices and tissue sections of vaginae co
OVX mice.
(F) Quantification of labeling index in VE of indicated groups (n = 3, ****p < 0.000
(G) Schematic of the timeline of doxycycline administration to Axin2rtTA/tetOH2BJ
(H) Bright-field images of organoids developed from Axin2– and Axin2+ cells.
(I) Quantification of organoid forming efficiency of Axin2– and Axin2+ cells (n =
The black dotted line demarcates VE from the adjoining stroma.
Data represents mean ± SEM.
Dox, doxycycline, E2, 17-b-estradiol, OVX, ovariectomized, L, lumen, S, stroma.
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cell markers (Axin2, Ngfr, Bmi1, and a signature of stem cells),
albeit at a lower level (Figures 5P–5S). We confirmed the expres-
sion of Axin2 mRNA using in situ hybridization-based analysis
of adult VE as well as vaginal organoids, which revealed that
the expression was indeed limited to a single layer of basal
cells (Figures 5T and 5U). The relatively higher expression of
Axin2 revealed by in situ hybridization-based analysis compared
to scRNA-seq data was expected due to a lower efficiency
(10% per molecule) of mRNA detection in droplet scRNA-seq
method (Salomon et al., 2019). Similar to Axin2 mRNA, the
expression of Ngfr was also limited to a single layer of basal cells
in vaginal organoids (Figure 5V).
So far, our results suggest that vaginal basal cells, which
survive hormonal deprivation, harbor a population of highly pro-
liferative cells, presumably vaginal stem cells, that are capable
of completely regenerating the entire VE upon E2 stimulation
(Figure 3). Interestingly, E2-mediated regeneration is finely cali-
brated by differential expression of Wnt signaling pathway mem-
bers (Figure 2). Moreover, clusters 0 in intact epithelium (Figure 1)
and 0, 1, and 2 in OVX epithelium (Figure S5), all of which localize
to the vaginal basal layer, show significant upregulation in Wnt
signaling pathway, which in turn is responsible for the prolifera-
tion and differentiation of these cells (Figure 2). Therefore, it
seems plausible that VE stem cells, presumably residing in the
basal layer, are Wnt-responsive cells. Given that one of the
classic Wnt-reporter genes that also faithfully marks Wnt-
responsive stem cells in several other regenerative organs is
Axin2 (Clevers et al., 2014), and that Axin2 is expressed exclu-
sively by a single layer of vaginal basal cells (Figures 5P and
5T), we decided to trace the fate of Axin2-derived cells to inves-
tigate their role as vaginal stem cells
Cell Lineage Tracing of Axin2+ Cells in VE
To determine the contribution of Axin2+ cells toward VE homeo-
stasis, we permanently labeled Axin2+ cells and followed the fate
of their progenies in normally cyclingmice (Figure 6A). Therefore,
we used doxycycline-inducible Axin2rtTA/tetOCre/lacZfl/+ mice to
pulse label Axin2+ cells stochastically with lacZ. Forty-eight
hours after the administration of a single dose of doxycycline
(2 mg), we found lacZ-labeled cells exclusively in the basal layerthe Entire VE
labeling and subsequent tissue collection. X-gal staining of thick vaginal slices
d d), 2 weeks (e and f), and 7 months (g and h) post-induction.
< 0.0001).
saturation. X-gal staining of thick vaginal slices and tissue sections at 0 days
for labeling at a single-cell density and subsequent hormone treatment and
llected 4 days after vehicle (a and b) or estrogen (E2) (c and d) treatment of
1).
GFP mice and FACS of Axin2+ and Axin2– cells for in vitro 3D culture.
5 mice; p = 0.0006).
Bar, 100 mm (500 mm for whole-mount and organoid images).
(Figures 6Aa and 6Ab), which was consistent with Axin2 mRNA
expression (Figure 5). Control mice without doxycycline expo-
sure did not show any lacZ expression (Figure S6). At subse-
quent chase points, these LacZ-labeled Axin2+ cells expanded,
and their progenies populated the entire VE, which was evident
as parallel streaks of lacZ+ cells originating from the base and
progressing through the suprabasal layer toward the lumen (Fig-
ures 6Ac–6Ah and 6B). This suggests that Axin2+ basal cells give
rise to all other epithelial cell lineages of VE.
One of the hallmarks of stem cells is their ability to self-renew
(Clevers et al., 2014). To investigate whether Axin2+ cells self-
renew, we labeled a maximum number of Axin2+ cells in
Axin2rtTA/tetOCre/lacZfl/+ mice by administering doxycycline at
high doses for an extended period of time (3 weeks) (Figure 6C).
At 0 days, lacZ+ basal cells and their progenies in the suprabasal
layers were present as parallel strips of labeled cells throughout
the VE (Figures 6Ca and 6Cb). Even after 10 months of chase,
this pattern of lacZ labeling was maintained in the VE. More
importantly, the proportion of labeled basal cells remained stable
throughout the chase (Figures 6Cc–6Cf and 6D). These data sug-
gest that Axin2+ cells self-renew and are not replaced by unla-
beled Axin2– cells.
Next, we tested the regenerative potential of Axin2+ basal cells.
Adult Axin2rtTA/tetOCre/lacZfl/+ mice were OVX to induce vaginal
epithelial atrophy. After a rest period of 14 days, mice were fed
doxycycline-treated water for 10 days (Figure 6E), which resulted
in the labeling of a subset of Axin2-expressing basal cells (Figures
6Ea and6Eb). Expectedly, administration of E2 completely regen-
erated the VE (Figures 6Ec and 6Ed). Importantly, the singly
labeled Axin2+ cells expanded and differentiated into labeled
suprabasal cells, repopulating the entire VE as shown by lacZ+
strips of basal cells and their progenies (Figures 6Ec and
6Ed and 6F). These results suggest that Axin2-expressing cells
are ovariectomy-resistant Wnt-responsive cells that robustly
contribute to VE regeneration upon E2 administration.
To investigate whether organoid forming ability is exclusive to
Axin2+ cells, we used fluorescence-activated cell sorting (FACS)
to sort Axin2+ and Axin2– cells from Axin2rtTA/tetOH2BJGFP mice
and cultured them to develop organoids (Figure 6G). On an
average, 11.33% ± 0.52% of Axin2+ cells formed organoids
compared to Axin2– cells (3.03% ± 0.68%) (Figures 6H and 6I).
Thus, organoid forming efficiency of Axin2+ cells is significantly
higher than that of Axin2– cells.
DISCUSSION
E2 signaling is a master regulator of reproductive tract functions,
and its dysregulation leads to many diseases including cancer
(Hewitt and Korach, 2018). E2 stimulates the proliferation and
differentiation of VE cells (Buchanan et al., 1998). VE cell-specific
deletion of estrogen receptor 1 (ESR1) in mice revealed that es-
trogen signaling is essential for the differentiation but not the
proliferation of VE (Li et al., 2018). This is supported by the obser-
vations in OVXmice and in vitro organ culture studies that epithe-
lial cells are able to proliferate at a baseline level in the absence
of E2 signaling (Gimenez-Conti et al., 1994; Tsai and Bern, 1991).
Comparative analysis of vaginae from the E2-treated control and
ESR1 knockout mice using DNA microarrays showed that 6 outof top 10 most upregulated genes in the control group belong to
Wnt signaling pathway (Miyagawa and Iguchi, 2015), suggesting
that E2-mediated effects on vagina might occur through Wnt
signaling. This is further supported by the findings that diethylstil-
bestrol treatment in mice affects Wnt signaling and causes
persistent upregulation of Wnt4 (Nakamura et al., 2012). Consis-
tently, we showed that treatment of OVX mice with E2 leads to
the upregulation of many Wnt ligands and the downstream tar-
gets. Our results also demonstrated that, even in the presence
of tamoxifen and intact functioning ovaries, basal/stem cells in
the VE of Ctnnb1cko mice were unable to undergo differentiation
to give rise to suprabasal cells. This suggests that canonical Wnt
signaling might be a key mediator of E2-induced differentiation
of VE cells.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d LEAD CONTACT AND MATERIALS AVAILABILITY
d EXPERIMENTAL MODEL AND SUBJECT DETAILSB Mice
B Epithelial cell isolation and organoid culture
B Cell lines
d METHOD DETAILS
B Targeting lacZ expression
B Histology and immunostaining
B Beta-galactosidase/X-gal staining
B CldU-IdU labeling
B Vaginal epithelial protein isolation and digestion for
proteomic analysis
B Mass spectrometry and database searching
B In Situ Hybridization (ISH)
B Wnt Signaling qPCR arrays
B Microscope image acquisition
d QUANTIFICATION AND STATISTICAL ANALYSIS
B Single Cell RNaseq analysis
B Statistical Analysis
d DATA AND CODE AVAILABILITYSUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.
celrep.2020.01.003.ACKNOWLEDGMENTS
We would like to thank Prof Jose Teixeira (Michigan State University) and
members of the Tanwar’s lab for critical reading and valuable inputs, Dr. Anne-
miek Beverdam (University of New South Wales) for help with K14cre mice,
Jyoti Goad, Varshini D. Venkata, Arnab Ghosh, and Annie Ko for technical
assistance, Nicole Cole (Analytical and Biomolecular Research Facility) for
FACS sorting, and Rob Salomon (Garvan Institute) for single-cell sequencing.
Work in the Tanwar’s lab was in part supported by funding from National
Health and Medical Research Council, Australian Research Council, and
Ovarian Cancer Research Foundation. D.G.-O. is supported by a Cancer Insti-
tute NSW Career Development Fellowship (DG00625).Cell Reports 30, 1463–1477, February 4, 2020 1475
AUTHOR CONTRIBUTIONS
Conceptualization, A.A., S.M.S., and P.S.T.; Methodology, A.A., S.M.S.,
M.F.B.J., Y.C.-S., D.G.-O., and P.S.T.; Investigation, A.A., S.M.S., and
P.S.T.; Data Collection and Analysis, A.A., S.M.S., M.F.B.J., Y.C.-S., D.G.-
O., and P.S.T.; Writing – Review & Editing, A.A., S.M.S., M.F.B.J., Y.C.-S.,
D.G.-O., and P.S.T.; Funding Acquisition, P.S.T.
DECLARATION OF INTERESTS
P.S.T. is an inventor on a patent application regarding vaginal organoid culture
and its uses. All other authors have no competing interests to declare.
Received: June 13, 2019
Revised: November 1, 2019
Accepted: December 30, 2019
Published: February 4, 2020
REFERENCES
Bonnans, C., Flacelière, M., Grillet, F., Dantec, C., Desvignes, J.P., Pannequin,
J., Severac, D., Dubois, E., Bibeau, F., Escriou, V., et al. (2012). Essential
requirement for b-arrestin2 in mouse intestinal tumors with elevated Wnt
signaling. Proc. Natl. Acad. Sci. USA 109, 3047–3052.
Boretto, M., Cox, B., Noben, M., Hendriks, N., Fassbender, A., Roose, H.,
Amant, F., Timmerman, D., Tomassetti, C., Vanhie, A., et al. (2017). Develop-
ment of organoids frommouse and human endometrium showing endometrial
epithelium physiology and long-term expandability. Development 144, 1775–
1786.
Bragulla, H.H., and Homberger, D.G. (2009). Structure and functions of keratin
proteins in simple, stratified, keratinized and cornified epithelia. J. Anat. 214,
516–559.
Buchanan, D.L., Kurita, T., Taylor, J.A., Lubahn, D.B., Cunha, G.R., and Cooke,
P.S. (1998). Role of stromal and epithelial estrogen receptors in vaginal epithe-
lial proliferation, stratification, and cornification. Endocrinology 139, 4345–
4352.
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., and Satija, R. (2018). Inte-
grating single-cell transcriptomic data across different conditions, technolo-
gies, and species. Nat. Biotechnol. 36, 411–420.
Caldas, H., Jiang, Y., Holloway, M.P., Fangusaro, J., Mahotka, C., Conway,
E.M., and Altura, R.A. (2005). Survivin splice variants regulate the balance be-
tween proliferation and cell death. Oncogene 24, 1994–2007.
Carson, D.D., DeSouza, M.M., Kardon, R., Zhou, X., Lagow, E., and Julian, J.
(1998). Mucin expression and function in the female reproductive tract. Hum.
Reprod. Update 4, 459–464.
Chen, B., Dodge, M.E., Tang, W., Lu, J., Ma, Z., Fan, C.W., Wei, S., Hao, W.,
Kilgore, J., Williams, N.S., et al. (2009). Small molecule-mediated disruption of
Wnt-dependent signaling in tissue regeneration and cancer. Nat. Chem. Biol.
5, 100–107.
Clevers, H. (2016). Modeling Development and Disease with Organoids. Cell
165, 1586–1597.
Clevers, H., Loh, K.M., and Nusse, R. (2014). Stem cell signaling. An integral
program for tissue renewal and regeneration: Wnt signaling and stem cell con-
trol. Science 346, 1248012.
Edgar, R. (2002). Gene Expression Omnibus: NCBI gene expression and hy-
bridization array data repository. Nucleic Acids Research 30, 207–210.
Edgren, R.A. (1959). The modification of estrogen-induced changes in rat va-
ginas with steroids and related agents. Ann. N Y Acad. Sci. 83, 160–184.
Gardner, W.U. (1959). Sensitivity of the vagina to estrogen: genetic and trans-
mitted differences. Ann. N Y Acad. Sci. 83, 145–159.
Ghosh, A., Syed, S.M., and Tanwar, P.S. (2017). In vivo genetic cell lineage
tracing reveals that oviductal secretory cells self-renew and give rise to ciliated
cells. Development 144, 3031–3041.1476 Cell Reports 30, 1463–1477, February 4, 2020Gimenez-Conti, I.B., Lynch, M., Roop, D., Bhowmik, S., Majeski, P., and Conti,
C.J. (1994). Expression of keratins in mouse vaginal epithelium. Differentiation
56, 143–151.
Goad, J., Ko, Y.A., Kumar, M., Syed, S.M., and Tanwar, P.S. (2017). Differential
Wnt signaling activity limits epithelial gland development to the anti-mesome-
trial side of the mouse uterus. Dev. Biol. 423, 138–151.
Grabherr, M.G., Haas, B.J., Yassour, M., Levin, J.Z., Thompson, D.A., Amit, I.,
Adiconis, X., Fan, L., Raychowdhury, R., Zeng, Q., et al. (2011). Full-length
transcriptome assembly from RNA-Seq data without a reference genome.
Nat. Biotechnol. 29, 644–652.
Hewitt, S.C., and Korach, K.S. (2018). Estrogen Receptors: New Directions in
the New Millennium. Endocr. Rev. 39, 664–675.
Hong, K.U., Reynolds, S.D., Watkins, S., Fuchs, E., and Stripp, B.R. (2004).
Basal cells are a multipotent progenitor capable of renewing the bronchial
epithelium. Am. J. Pathol. 164, 577–588.
Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G., andBirchmeier,W. (2001).
beta-Catenin controls hair follicle morphogenesis and stem cell differentiation
in the skin. Cell 105, 533–545.
Kaushik, G., Ponnusamy, M.P., and Batra, S.K. (2018). Concise Review: Cur-
rent Status of Three-Dimensional Organoids as Preclinical Models. Stem Cells
36, 1329–1340.
Kobayashi, A., and Behringer, R.R. (2003). Developmental genetics of the
female reproductive tract in mammals. Nat. Rev. Genet. 4, 969–980.
Kumar, M., and Tanwar, P.S. (2017). Canonical Wnt/b-Catenin Signaling
Regulates Postnatal Mouse Epididymal Development But Does Not Affect
Epithelial Cell Differentiation. Endocrinology 158, 4286–4299.
Kurita, T., Cunha, G.R., Robboy, S.J., Mills, A.A., and Medina, R.T. (2005). Dif-
ferential expression of p63 isoforms in female reproductive organs. Mech. Dev.
122, 1043–1055.
Lavrik, I., Golks, A., and Krammer, P.H. (2005). Death receptor signaling. J. Cell
Sci. 118, 265–267.
Lee, Y., Dizzell, S.E., Leung, V., Nazli, A., Zahoor, M.A., Fichorova, R.N., and
Kaushic, C. (2016). Effects of Female Sex Hormones on Susceptibility to
HSV-2 in Vaginal Cells Grown in Air-Liquid Interface. Viruses 8, E241.
Li, S., Herrera, G.G., Tam, K.K., Lizarraga, J.S., Beedle, M.T., and Winuthaya-
non, W. (2018). Estrogen Action in the Epithelial Cells of the Mouse Vagina
Regulates Neutrophil Infiltration and Vaginal Tissue Integrity. Sci. Rep. 8,
11247.
Macosko, E.Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tir-
osh, I., Bialas, A.R., Kamitaki, N., Martersteck, E.M., et al. (2015). Highly Par-
allel Genome-wide Expression Profiling of Individual Cells Using Nanoliter
Droplets. Cell 161, 1202–1214.
Mehta, F.F., Son, J., Hewitt, S.C., Jang, E., Lydon, J.P., Korach, K.S., and
Chung, S.H. (2016). Distinct functions and regulation of epithelial progesterone
receptor in the mouse cervix, vagina, and uterus. Oncotarget 7, 17455–17467.
Mejetta, S., Morey, L., Pascual, G., Kuebler, B., Mysliwiec, M.R., Lee, Y., Shie-
khattar, R., Di Croce, L., and Benitah, S.A. (2011). Jarid2 regulates mouse
epidermal stem cell activation and differentiation. EMBO J. 30, 3635–3646.
Miyagawa, S., and Iguchi, T. (2015). Epithelial estrogen receptor 1 intrinsically
mediates squamous differentiation in the mouse vagina. Proc. Natl. Acad. Sci.
USA 112, 12986–12991.
Miyoshi, H., and Stappenbeck, T.S. (2013). In vitro expansion and genetic
modification of gastrointestinal stem cells in spheroid culture. Nat. Protoc. 8,
2471–2482.
Nakamura, T., Miyagawa, S., Katsu, Y., Watanabe, H., Mizutani, T., Sato, T.,
Morohashi, K., Takeuchi, T., Iguchi, T., and Ohta, Y. (2012). Wnt family genes
and their modulation in the ovary-independent and persistent vaginal epithelial
cell proliferation and keratinization induced by neonatal diethylstilbestrol
exposure in mice. Toxicology 296, 13–19.
Nusse, R. (2008). Wnt signaling and stem cell control. Cell Res. 18, 523–527.
Ousset, M., Van Keymeulen, A., Bouvencourt, G., Sharma, N., Achouri, Y., Si-
mons, B.D., and Blanpain, C. (2012). Multipotent and unipotent progenitors
contribute to prostate postnatal development. Nat. Cell Biol. 14, 1131–1138.
Pacal, M., and Bremner, R. (2012). Mapping differentiation kinetics in the
mouse retina reveals an extensive period of cell cycle protein expression in
post-mitotic newborn neurons. Dev. Dyn. 241, 1525–1544.
Papafotiou, G., Paraskevopoulou, V., Vasilaki, E., Kanaki, Z., Paschalidis, N.,
and Klinakis, A. (2016). KRT14 marks a subpopulation of bladder basal cells
with pivotal role in regeneration and tumorigenesis. Nat. Commun. 7, 11914.
Perez-Llamas, C., and Lopez-Bigas, N. (2011). Gitools: analysis and visualisa-
tion of genomic data using interactive heat-maps. PLoS ONE 6, e19541.
Plasschaert, L.W., Zilionis, R., Choo-Wing, R., Savova, V., Knehr, J., Roma, G.,
Klein, A.M., and Jaffe, A.B. (2018). A single-cell atlas of the airway epithelium
reveals the CFTR-rich pulmonary ionocyte. Nature 560, 377–381.
Rock, J.R., Onaitis, M.W., Rawlins, E.L., Lu, Y., Clark, C.P., Xue, Y., Randell,
S.H., and Hogan, B.L. (2009). Basal cells as stem cells of the mouse trachea
and human airway epithelium. Proc. Natl. Acad. Sci. USA 106, 12771–12775.
Salomon, R., Kaczorowski, D., Valdes-Mora, F., Nordon, R.E., Neild, A., Far-
behi, N., Bartonicek, N., and Gallego-Ortega, D. (2019). Droplet-based single
cell RNAseq tools: a practical guide. Lab Chip 19, 1706–1727.
Savidis, G., Perreira, J.M., Portmann, J.M., Meraner, P., Guo, Z., Green, S.,
and Brass, A.L. (2016). The IFITMs Inhibit Zika Virus Replication. Cell Rep.
15, 2323–2330.
Schneider, C.A., Rasband, W.S., and Eliceiri, K.W. (2012). NIH Image to Im-
ageJ: 25 years of image analysis. Nat. Methods 9, 671–675.
Sobecki, M., Mrouj, K., Colinge, J., Gerbe, F., Jay, P., Krasinska, L., Dulic, V.,
and Fisher, D. (2017). Cell-Cycle Regulation Accounts for Variability in Ki-67
Expression Levels. Cancer Res. 77, 2722–2734.Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre reporter
strain. Nat. Genet. 21, 70–71.
Tanimura, S., Tadokoro, Y., Inomata, K., Binh, N.T., Nishie, W., Yamazaki, S.,
Nakauchi, H., Tanaka, Y., McMillan, J.R., Sawamura, D., et al. (2011). Hair fol-
licle stem cells provide a functional niche for melanocyte stem cells. Cell Stem
Cell 8, 177–187.
Tanwar, P.S., Zhang, L., Tanaka, Y., Taketo, M.M., Donahoe, P.K., and Teix-
eira, J.M. (2010). Focal Mullerian duct retention inmale mice with constitutively
activated beta-catenin expression in the Mullerian duct mesenchyme. Proc.
Natl. Acad. Sci. USA 107, 16142–16147.
Teta, M., Rankin, M.M., Long, S.Y., Stein, G.M., and Kushner, J.A. (2007).
Growth and regeneration of adult beta cells does not involve specialized pro-
genitors. Dev. Cell 12, 817–826.
Tsai, P.S., and Bern, H.A. (1991). Estrogen-independent growth of mouse
vaginal epithelium in organ culture. J. Exp. Zool. 259, 238–245.
Tuttle, A.H., Rankin, M.M., Teta, M., Sartori, D.J., Stein, G.M., Kim, G.J., Virgi-
lio, C., Granger, A., Zhou, D., Long, S.H., et al. (2010). Immunofluorescent
detection of two thymidine analogues (CldU and IdU) in primary tissue.
J. Vis. Exp. 46, 2166.
Valdes-Mora, F., Salomon, R., Gloss, B., Law, A.M., Murphy, K., Roden, D.L.,
Castillo, L., Colino-Sanguino, Y., Kikhtyak, Z., Farbehi, N., et al. (2019). Single-
cell RNAseq uncovers involutionmimicry as an aberrant development pathway
during breast cancer metastasis. bioRxiv. https://doi.org/10.1101/624890.
Vasioukhin, V., Degenstein, L., Wise, B., and Fuchs, E. (1999). The magical
touch: genome targeting in epidermal stem cells induced by tamoxifen appli-
cation to mouse skin. Proc. Natl. Acad. Sci. USA 96, 8551–8556.Cell Reports 30, 1463–1477, February 4, 2020 1477
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rat anti-BrdU (BU1/75(ICR1)) Accurate Chemical & Scientific
Corporation
Cat#OBT0030G; RRID: AB_609567
Mouse anti-BrdU (B44) BD Biosciences Cat#347580; RRID: AB_400326
Mouse anti-bcatenin BD Transduction Laboratories Cat#610154; RRID: AB_397555
Rabbit anti-Ki67 Abcam Cat#ab15580; RRID: AB_443209
Rabbit Anti-p75 NGF Receptor Abcam Cat# ab8875; RRID:AB_306828
Tp63 (H-137) Santa Cruz Biotechnology Cat# sc-8343; RRID:AB_653763
Rabbit Anti- Keratin 1 Covance Research Products Inc Cat# PRB-165P-100; RRID:AB_291583
Rabbit anti-Keratin 5 Abcam Cat# ab52635; RRID:AB_869890
Rabbit anti-Keratin 17 Abcam Cat# ab109725; RRID:AB_10889888
Rabbit anti-Filaggrin BioLegend Cat# 905801; RRID:AB_2565053
Rabbit anti-Survivin (Birc5) Cell Signaling Technology Cat# 2808; RRID:AB_2063948
Rabbit anti- FABP5 Cell Signaling Technology Cat# 39926; RRID:AB_2799165
Rabbit anti-IFITM3 Proteintech Group Cat# 11714-1-AP; RRID:AB_2295684
Alexa Fluor 488 goat anti-rat IgG (F(ab‘)2) Jackson ImmunoResearch Labs Cat#112-545-072; RRID: AB_2338359
Alexa Fluor 488 goat anti-mouse IgG (F(ab‘)2) Jackson ImmunoResearch Labs Cat#115-545-072; RRID: AB_2338848
Alexa Fluor 594 goat anti-rabbit IgG (F(ab‘)2) Jackson ImmunoResearch Labs Cat#111-585-047; RRID: AB_2338064
Peroxidase goat anti-rabbit IgG (F(ab‘)2) Jackson ImmunoResearch Labs Cat#111-036-047; RRID: AB_2337945
Alexa Fluor 647 goat anti-rabbit IgG (H + L) Thermo Fisher Scientific Cat#A-21245; RRID:AB_2535813
Alexa Fluor 555 goat anti-mouse IgG (H + L) Thermo Fisher Scientific Cat# A32727; RRID:AB_2633276
Chemicals, Peptides, and Recombinant Proteins
Pronase Sigma-Aldrich Cat#10165921001
DNase I Sigma-Aldrich Cat#10104159001
Fetal Bovine Serum Bovogen Cat#SFBS-F
L-glutamine HyClone Cat#SH30034.01
Penicillin-streptomycin Thermo Fisher Scientific Cat#15070-063
Matrigel Trevigen Cat#3433-010-01
Mouse EGF recombinant Sigma-Aldrich Cat#SRP3196
Y-27632 dihydrochloride Tocris Cat#1254
SB431542 TGF beta inhibitor Seleckchem Cat#S1067
Ultra serum-G PALL Cat#15950-017
TrypLE express Thermo Fisher Scientific (GIBCO) Cat#12604-021
Doxycycline hyclate (lot#086M4035V) Sigma-Aldrich Cat#D9891
Neutral Red Sigma-Aldrich 72210
DMEM/F12 HAM Sigma-Aldrich Cat#D8437
HBSS/Modified HyClone Cat#SH30031.02
Tamoxifen (Lot#SLBF8049V) Sigma-Aldrich Cat#T5648; CAS#10540-29-1
b-Estradiol (Lot#SLBH0091V) Sigma-Aldrich Cat#E8875; CAS#50-28-2
DAPI dilactate Sigma-Aldrich Cat#D9564
Paraformaldehyde 16% solution EM Grade Electron Microscopy Sciences Cat#15710
Xgal (Lot#ES531-B061890) Bioline Cat#BIO-37035
5-Chloro-2‘-Deoxyuridine (Lot#QR10915) MP Biochemicals LLC. Cat#105478; CAS#50-90-8
5-Iodo-2‘-Deoxyuridine (Lot#BCBP3111V) Sigma-Aldrich Cat#17152
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Critical Commercial Assays
RNeasy Micro Kit QIAGEN Cat#74004
Qubit 2.0 Fluorometer assay Invitrogen N/A
RNAscope 2.5 HD Assay-RED kit ACD 322350
RNAscope 2.5 HD Detection Reagents-RED ACD 322360
RNAscope H202 & Protease Plus Reagents ACD 322330
RNAscope Negative Control Probe - DapB ACD 310043
RNAscope Positive Control Probe - Mm-Ppib ACD 313911
Probe-Mm-Axin2 ACD 400331
Probe -Mm-Dkk1 ACD 402521
Probe - Mm-Dkk2 ACD 404841
Probe -Mm-Dkk3 ACD 400931
Probe -Mm-Dkk-4 ACD 404851
Probe - Mm-Sfrp2 ACD 400381
Probe -Mm-Sfrp4 ACD 404991
Probe - Mm-Frzb ACD 404861
Probe - Mm-Sfrp1 ACD 404981
Probe - Mm-Sfrp5 ACD 405001
Probe - Mm-Wif1 ACD 412361
Probe - Mm-Wnt1 ACD 401091
Probe - Mm-Wnt10a ACD 401061
Probe - Mm-Wnt10b ACD 401071
Probe - Mm-Wnt2 ACD 313601
Probe - Mm-Wnt2b ACD 405031
Probe -Mm-Wnt11 ACD 405021
Probe -Mm-Wnt16 ACD 401081
Probe -Mm-Wnt4 ACD 401101
Probe -Mm-Wnt7a ACD 401121
Probe -Mm-Wnt7b ACD 401131
Probe - Mm-Wnt3 ACD 312241
Probe - Mm-Wnt3a ACD 405041
Probe - Mm-Wnt5a ACD 316791
Probe - Mm-Wnt5b ACD 405051
Probe - Mm-Wnt6 ACD 40111
Probe - Mm-Wnt8a ACD 405061
Probe - Mm-Wnt8b ACD 405071
Probe - Mm-Wnt9a ACD 405081
Probe - Mm-Wnt9b ACD 405091
Deposited Data
scRNA-seq data This paper GEO: GSE142212
Experimental Models: Cell Lines
L-WRN cells ATCC Cat#CRL-3276; RRID: CVCL_DA06
Experimental Models: Organisms/Strains
Mouse STOCK Tg(KRT14-cre/ERT)20Efu/J The Jackson laboratory JAX:005107, RRID:IMSR_JAX:005107
Mouse: Axin2rtTA: B6.Cg-Tg(Axin2-rtTA2S*M2)7Cos/J The Jackson Laboratory JAX:016997; RRID:IMSR_JAX:016997
Mouse: tetOCre: STOCK Tg(tetO-cre)1Jaw/J The Jackson Laboratory JAX:006224; RRID:IMSR_JAX:006224
Mouse: tetOH2BJGFP: STOCK Tg(tetO-HIST1H2BJ/GFP)47Efu/J The Jackson Laboratory JAX:005104; RRID:IMSR_JAX:005104
(Continued on next page)
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Mouse: R26-lacZfl/fl: B6.129S4-Gt(ROSA)26Sortm1Sor/J The Jackson Laboratory JAX:003474; RRID:IMSR_JAX:003474
Mouse: Ctnnb1fl/fl: B6.129-Ctnnb1tm2Kem/KnwJ The Jackson Laboratory JAX:004152; RRID:IMSR_JAX:004152
Oligonucleotides
Mouse Gapdh Forward# TGGCAAAGTGGAGATTGTTGCC Bonnans et al., 2012 N/A
Mouse Gapdh Reverse# AAGATGGTGATGGGCTTCCCG Bonnans et al., 2012 N/A
Mouse Axin2 Forward# CGACCCAGTCAATCCTTATCAC Boretto et al., 2017 N/A
Mouse Axin2 Reverse# GGGACTCCATCTACGCTACTG Boretto et al., 2017 N/A
Mouse Keratin1 Forward# GACACCACAACCCGGAC
CCAAAACTTAG
Mejetta et al., 2011 N/A
Mouse Keratin1 Reverse# ATACTGGGCCTTGACTTCC
GAGATGATG
Mejetta et al., 2011 N/A
Mouse Filaggrin Forward# GGAGGCATGGTGGAACTGA Mejetta et al., 2011 N/A
Mouse Filaggrin Reverse# TGTTTATCTTTTCCCTCAC
TTCTACATC
Mejetta et al., 2011 N/A
Mouse Ctnnb1 Forward# AGACAGCTCGTTGTACTGCT Kumar and Tanwar, 2017 N/A
Mouse Ctnnb1 Reverse# GTGTCGTGATGGCGTAGAAC Kumar and Tanwar, 2017 N/A
Software and Algorithms
Proteome Discoverer software version 2.1 Thermo Fisher Scientific N/A
Gitools 2.3.1 software Perez-Llamas and Lopez-
Bigas, 2011
http://www.gitools.org
ImageJ Schneider et al., 2012 https://imagej.nih.gov/ij/
GraphPad Prism version 7.02 GraphPad Software, La Jolla
California USA
https://www.graphpad.comLEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Assoc.
Prof. Pradeep Tanwar (Pradeep.tanwar@newcastle.edu.au). All unique/stable reagents generated in this study are available from the
Lead Contact without restriction.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
All the experimental procedures with mice were approved by the Animal Care and Ethics Committee of The University of Newcastle,
Australia. The guidelines of New South Wales Animal Research Act, New South Wales Animal Research Regulation, and the Austra-
lian Code for the care and use of animals for the scientific purposes, were followed for animals’ care and experimental procedures. All
the animals were maintained on C57BL/6; 129SvEv mixed genetic background. Mice had access to food and water ad libitum and
were maintained under 12-hour dark/light cycle. For tracing the fate of vaginal epithelium, K14CreERT2 (Vasioukhin et al., 1999) mice
were bred with Gt(ROSA)26Sortm1Sor/J (lacZfl/fl) (Soriano, 1999) to generate K14CreERT2/lacZfl/+ mice. For deletion of bcatenin gene
(Ctnnb1) in vaginal epithelium, K14CreERT2 mice were bred with Ctnnb1fl/fl (Huelsken et al., 2001) mice to generate K14CreERT2/
Ctnnb1fl/fl mice. For tracing lineage of Axin2-expressing cells, Axin2rtTA/tetOCre mice were bred with lacZfl/fl mice to generate
Axin2rtTA/tetOCre/lacZfl/+ mice. For genotyping, DNA was extracted from mice ear clips using REDExtract-N-Amp Tissue PCR Kit
(Sigma) and PCRs were performed using a standard protocol (Goad et al., 2017). Axin2rtTA mice were bred with tetOH2BJGFP mice
to generate Axin2rtTA/tetOH2BJGFP mice. For single cell RNaseq analysis, vaginal epithelial cells were isolated from 6w old adult
C57Bl6 wild-type mice and ovariectomized (OVX) mice.
Epithelial cell isolation and organoid culture
The vaginae of 6w old adult mice were dissected out, washed with Ca2+ and Mg2+ free Hanks Balanced Salt Solution (HBSS), and
were slit open to expose the epithelium during subsequent enzymatic digestion. The tissues were placed in DMEM/F12 containing
1mg/ml Pronase (Sigma) and 0.5mg/ml DNase1 (Sigma) at 4C overnight with slow shaking. Enzymatic digestion was stopped by
adding DMEM/F12 medium (Sigma) supplemented with 10% fetal bovine serum (Bovogen). The epithelium was then squeezed
out with the help of a pair of forceps under the dissecting microscope. Following two successive washes in DMEM/F12, the singlee3 Cell Reports 30, 1463–1477.e1–e7, February 4, 2020
cell suspension was prepared using 40mm cell strainer before plating. For organoid culture, 10,000 cells were resuspended in 25ml
Matrigel and cultured in DMEM/F12 supplemented with 2% Ultraserum-G (PALL Corporation), 1% Penicillin-Streptomycin (Lonza),
50ng/ml mouse EGF (Sigma), 0.5mM A83-01 (TGFb/Alk inhibitor) (Sellekchem) and 10mM Y-27632 dihydrochloride (ROCK inhibitor)
(Tocris). The medium was changed every 2 days. The organoids were imaged on JuLiTM Stage Real-Time Cell History Recorder
(NanoEnTek, ROK) at different time points, and the number of organoids formed was quantified using ImageJ (NIH).
Axin2rtTA/ tetOH2BJGFPmice were used for FACS sorting of GFP+ (Axin2+) and GFP- (Axin2-) cells. FACS sorting was performed on a
FACSAria2 sorter using the FACS DiVa (software version 6.1.3) (BD Biosciences). Dead cells were excluded with propidium iodide.
FACS sorted cells were resuspended in Matrigel and cultured in DMEM/F12 complete media.
To study the effect of E2 on organoids, cells were isolated from vaginae of 6w old adult mice and were culture in media supple-
mented with 100ng/ml b-estradiol (Sigma).
For long term organoid culture of cells, media was changed every 3 days and passaging was done every 10 days. Briefly, Matrigel
droplets containing organoids were dissolved in ice-cold DPBS. Organoids were dissociated into single cells by incubation in TrypLE
express (Thermo Fisher Scientific) at 37C for 10mins. Trypsinization was stopped by adding DMEM/F12medium supplemented with
10% fetal bovine serum. Cell clumps were further dissociated into single cells by gentle pipetting and were reseeded in Matrigel
droplets.
For modulation of Wnt signaling, organoids were cultured in complete media supplemented with WRN conditioned media at
various concentrations of 5%, 10%, 25% and 50%.
Cell lines
The L-WRN cell line (ATCC CRL-3276) expressing Wnt3A, Rspondin3 and noggin was used for producingWRN conditioned medium
(Miyoshi and Stappenbeck, 2013).
METHOD DETAILS
Targeting lacZ expression
K14CreERT2/lacZfl/+ and Axin2rtTA/tetOCre/lacZfl/+ female mice express lacZ-encoded b galactosidase in all cells derived from K14-
expressing cells and Axin2-expressing cells, respectively.
For lineage tracing, 6w-old K14CreERT2/lacZfl/+ mice were injected with tamoxifen (2mg per mouse per day) intraperitoneally for
three alternate days. Upon tamoxifen administration, K14CreERT2/lacZfl/+ express lacZ (bgal) in K14-expressing cells and their prog-
enies. K14CreERT2/Ctnnb1fl/+ were injected with tamoxifen (1mg per mouse per day) intraperitoneally for 5 consecutive days to
induce deletion of Ctnnb1 (Ctnnb1cko) from K14 expressing cells and their progenies. For regeneration experiment, K14CreERT2/
lacZfl/+ mice were ovariectomized at 6w age, and allowed to recover for 2w, after which they were induced with a single dose of
5mg tamoxifen intraperitoneally. Mice vaginae were collected at different time points for further analysis.
For lineage tracing, 6w old Axin2rtTA/tetOCre/lacZfl/+ mice were induced by feeding doxycycline in drinking water (5 mg/ml, supple-
mented with 5% sucrose) for 3w. To initiate labeling at single cell density, and subsequent lineage tracing, Axin2rtTA/tetOCre/lacZfl/+
female mice were induced with 2mg of doxycycline (dissolved in sterile PBS) by intraperitoneal injection at 6w of age. For regener-
ation experiment, Axin2rtTA/tetOCre/lacZfl/+were ovariectomized (OVX) at 6w of age, and allowed to recover for 2w, after which doxy-
cycline was administered to induce labeling at single cell density. Ten days after doxycycline administration, Axin2rtTA/tetOCre/lacZfl/+
mice were further injected subcutaneously with 400 ng 17b-oestradiol (Sigma) dissolved in sesame oil (four injections of 100ng every
day) to allow regeneration of hormone-deprivation induced atrophied vagina. Mice were sacrificed 24 hours after the last injection
and processed for tissue collection. Littermates were used as the control for all experiments.
Histology and immunostaining
Vaginal tissues collected from different mice were fixed in 4% paraformaldehyde at 4C overnight and then processed for paraffin
embedding. IF/IHC were performed as described in Ghosh et al. (2017). The following primary antibodies were used rabbit anti-
Tp63 (1:500), rabbit anti-Ki67 (1:500), rabbit anti-keratin 1 (1:500), rabbit anti-filaggrin (1:500), mouse anti-b-catenin (1:200), rabbit
Anti-p75 NGF Receptor (1:250), rabbit anti-keratin5 (1:1000), rabbit anti-keratin17 (1:250), rabbit anti-survivin (Birc5) (1:250), rabbit
anti-FABP5 (1:500), rabbit anti-IFITM3 (1:500). The following secondary antibodies were used: anti-rabbit, anti-rat, anti-mouse con-
jugated to HRP or AlexaFluor 488/594 (1:250), anti-rabbit conjugated to AlexaFluor 647 (1:250) and anti-mouse conjugated to Alexa-
fluor 555 (1:250). For immunofluorescence, nuclei were stained with 4’, 6-diamidino-2-phenylindole (DAPI) and mounted in buffered
glycerol. For immunohistochemistry, EnVisionTM+ Dual Link System-HRP (DAB+) kit was used as per manufacturer instructions.
Nuclei were counterstained with hematoxylin and mounted in toluene-based Cytoseal mounting medium (ProSciTech).
Beta-galactosidase/X-gal staining
X-gal staining for the presence of b-galactosidase/LacZ activity has been described previously (Ghosh et al., 2017). Briefly, vaginae
from K14CreERT2/lacZfl/+ and Axin2rtTA/tetOCre/lacZfl/+ female mice were fixed in 4% paraformaldehyde (PFA) at 4C for 1h. Vaginal
tissue slices of 125mm thickness were prepared using McIlwain Tissue Chopper. Post-fixed tissues were washed 3 times in rinse
buffer [0.1% sodium deoxycholate, 0.2% NP40, 2mM MgCl2 in 0.1M phosphate buffer (pH 7.3)] for 30 minutes each at roomCell Reports 30, 1463–1477.e1–e7, February 4, 2020 e4
temperature. The sections were incubated in X-gal solution for 20-24h at room temperature, followed by fixation in 4% PFA at 4C
overnight, and processed for paraffin embedding. Tissue sections were cut at 8mm thickness and counterstained with nuclear fast
red. Combined X-gal/immunostaining procedures were performed on 6 mm tissue sections as per standard immunostaining protocol.
CldU-IdU labeling
CldU and IdU were dissolved in sterile PBS and injected intra-peritoneally into mice at a dose of 100mg/kg. To test the specificity of
these two antisera, we labeled 6w old female mice sequentially with CldU and then IdU (Figure S2). For labeling, mice received intra-
peritoneal injection of CldU and IdU (100mg/g body weight, made up as 10mg/ml in PBS) and tissues were analyzed 24h later. Due to
the well-established location of the rapidly dividing progenitors (stem/transit amplifying compartments), we used intestines for these
labeling strategies. Cells that had undergone replication during the first labeling periodwhenCldUwas given (Figure S2) were positive
for CldU. Such cells were located in the middle of the villi. Presumably this first cell division occurred within crypts and subsequently
the cells migrated up the villi. On the other hand, DNA analog injected later, IdU, was more localized in the crypt bases in which
recently dividing cells are presumably located (Figure S2b). Importantly, CldU-IdU co-positive epithelial cells were present within
the crypts (Figure S2), where stem/TA compartment is known to exist. These results confirmed the specificity of anti-CldU and
anti-IdU antisera.
For IdU label dilution, 6w old female mice were given access to water supplemented with 1mg/ml IdU ad libitum for up to 7d (Fig-
ure 3B). For short-term labeling, 6w old female mice received intraperitoneal injections of CldU (100mg/g body weight, made up as
10mg/ml in PBS) and IdU (100mg/g body weight, made up as 10mg/ml in PBS) on consecutive days and were sacrificed 24h later
(Figure 3C). For long-term labeling in OVX mice, 6w old female mice were first ovariectomized. After recovery period of 14d, mice
were given access to water supplemented with 1mg/ml CldU ad libitum for up to 2w. This was followed by a washout period of
5d, after which mice were given access to water supplemented with 1mg/ml IdU ad libitum for another 2w, and then sacrificed
24h later (Figure 3D). Bottles containing CldU and IdU water were changed every 3d and were covered with aluminum foil to prevent
light exposure.
Immunostaining for CldU and IdU was performed as described previously (Tuttle et al., 2010). Briefly, 5 mm paraffin embedded tis-
sue sections were deparaffinized, rehydrated, heated to 110C for 30 min in 1 mM EDTA buffer (pH 8.0) for antigen retrieval, permea-
bilized with 0.2% Triton, incubated in 1.5 N HCl, incubated in blocking buffer (10%Normal Goat Serum/ 0.1% Triton in PBS) for 1 h at
room temperature, before an overnight incubation for IdUwith mouse anti-BrdU antisera (mouse, 1:250). Sections were then washed
and incubated overnight with rabbit anti-Tp63 antisera (1:500) and rat anti-BrdU antisera (1:250) for CldU, followed by incubation with
secondary antibodies conjugated to AlexaFluor 488, AlexaFluor 594 and AlexaFluor 647. Nuclei were stained with 4’, 6-diamidino-2-
phenylindole (DAPI) and mounted in buffered glycerol.
Vaginal epithelial protein isolation and digestion for proteomic analysis
Vaginal epithelial protein preparations from three respective conditions of Ctnnb1 (bcatenin) deletion after 1w, 2w, and 8w (n = 3 per
time point) of tamoxifen treatment were generated for analysis. Vaginal epithelial tissues were then resuspended in ice-cold lysis
buffer containing 0.1 M Na2CO3 pH 11.3 supplemented with protease (Sigma) and phosphatase inhibitors (Roche, IN, USA). Tissue
samples were homogenized using a beadbug homogenizer (Benchmark Scientific) until a homogeneous suspension is obtained, and
incubated for 1h at 4C. The soluble proteins were then dissolved in 6Murea and 2M thiourea, reducedwith 10mMdithiothreitol (DTT)
for 30 minutes at room temperature and subsequently, alkylated using 20 mM iodoacetamide (Sigma) in the dark for 30 minutes.
Proteins were then digested with Lys-C/trypsin (Promega) at a protease-to-protein ratio of 1:25 at room temperature for 3h. After-
ward, samples were diluted with 50 mM triethylammonium bicarbonate, pH 7.8 to reduce the urea concentration to 0.75 M and
were digested overnight at room temperature. Desalting of peptide was carried out using the solid phase extraction (SPE) columns
(Oasis PRIMEHLB,Waters, Rydalmere) and a vacuummanifold (Supelco) according tomanufacturer’s instructions. Peptide concen-
trations were determined using a Qubit 2.0 Fluorometer assay (Invitrogen).
Mass spectrometry and database searching
For LC-MS/MS processing, digested peptide solutions were first dried down in a SpeedVac SC100 (Thermo Fisher Scientific), res-
olubilized in 2% acetonitrile/0.1% trifluoroacetic acid. 500 ng of each peptide sample were measured using nanoflow LC instrument
interfaced to aQExactive Plus Orbitrapmass spectrometer (Thermo Fisher Scientific), which is equippedwith a nanoelectrospray ion
source. Peptides were loaded onto a trapping column (Acclaim PepMapTM100, 100 mm x 2 cm, nanoViper fitting C18, 5 mm, 100 Å,
Thermo Fisher Scientific) for pre-concentration, and then resolved in the analytical column (EASY-Spray Column, PepMap, 75 mm x
25 cm, nanoviper fitting, C18, 2 mm, 100 Å, Thermo Fisher Scientific) for peptide separation. Solvent A was 0.1% formic acid in HPLC
water, and solvent Bwas 0.1% formic acid in acetonitrile (Acn). The separation of the peptides was achieved at a constant flow rate of
250 nl/min using a linear gradient from 2% to 35% of solvent B over 95 minutes. Ions were generated by positive electrospray ioni-
zation via liquid junction into a Q Exactive mass spectrometer. Mass spectra were acquired over m/z 380 – 2,000 at 70,000 resolution
and data-dependent acquisition selected the top twenty most abundant precursor ions for tandemmass spectrometry by HCD frag-
mentation, collision energy of 32.0, and a resolution of 35,000. Dynamic exclusion was set at 15 s, as well as rejection of precursor
ions with charge state +1, were employed to minimize redundant MS/MS collection and maximize peptide identifications. The MS
raw files were processed using Proteome Discoverer (PD) software (version 2.1, Thermo Fisher Scientific) were search against thee5 Cell Reports 30, 1463–1477.e1–e7, February 4, 2020
mouse protein database (updated to April 2018). The mass tolerance of precursor mass and fragment mass were set as 10 ppm and
0.02 Da respectively. S-carbamidomethylation of cysteine was set as a fixed modification and asparagine deamidated as dynamic
modifications. For digestion, trypsin was set as the digestion enzyme with two missed cleavage permitted. A fixed false discovery
rate (FDR) was set at < 1% for identification of peptides and proteins. Only keratin and filaggrin proteins represented by at least
two unique peptides were included in the analysis. Data were analyzed using Gitools 2.3.1 software to generate heatmaps and a pro-
tein is considered upregulated if the level of expression was 1.5-fold higher than the 1w b-catenin deletion and downregulated if it was
0.66-fold lower than the 1w b-catenin deletion.
In Situ Hybridization (ISH)
ISH was performed as described in Goad et al. (2017). Vaginae were collected from 4w-old mice (n = 4) and 6w old adult mice across
the estrus cycle stages (n = 3). Tissues were fixed in 10% buffered formalin (Sigma) for 24h at room temperature and then processed
for paraffin embedding and sectioned at 4mm thickness. Probe details in the key resource table.
Wnt Signaling qPCR arrays
Total RNA was extracted from 6w old adult OVX and E2-treated vaginal tissues using QIAGEN RNeasy Micro kit as per manufac-
turer’s instructions (QIAGEN). RNA was quantified and equal concentrations used for cDNA synthesis with RT2 First Strand Kit
(QIAGEN). QPCR was then performed using RT2 SYBR Green ROX qPCR Mastermix (QIAGEN) and RT2 Profiler PCR Array Kit
(QIAGEN) on ABI 7900 HT FAST (Applied Biosciences) as described in Goad et al. (2017). Data were analyzed as per manufacturer’s
instructions, and the reactions were normalized against the five housekeeping genes included in the arrays. To study the mRNA
expression levels forCtnnb1,K1 and Flg, RNAwas isolated from the vaginal epithelium ofCtnnb1fl/fl andCtnnb1cko using the RNeasy
Micro Kit (QIAGEN) following the manufacturer’s instructions. qRT-PCR was performed as detailed in Ghosh et al. (2017).
Microscope image acquisition
Images of immunostaining were acquired with Olympus BX51 upright fluorescence microscope equipped with Olympus UPlanFLN
objectives (x40, NA = 0.75; x60, NA = 0.9) and Olympus DP72 CCD (charge-coupled device) color camera using cellSens software
(Olympus), or Zeiss AxioImager A1 upright fluorescence microscope equipped with AxioCam MRc camera and Zeiss EC Plan-
NEOFLUAR objectives (x20, NA = 0.5; x40, NA = 0.75) using ZEN software or Olympus Fluoview FV10i upright confocal laser scan-
ning microscope fitted with 60x oil-immersion objective (NA = 1.35) (Olympus), using FV10i-SW software. Whole mount imaging of
100um thick slices of X-gal stained vaginae was done on SMZ25 stereoscope equipped with Nikon DS-Fi2 camera and Nikon P2-
SHR Plan Apo 2X objective (NA = 0.312). Images consisted of 15–30 stacks with variable z-spacing and were captured and merged
using NIS-Elements software. All images were captured at room temperature.
QUANTIFICATION AND STATISTICAL ANALYSIS
Single Cell RNaseq analysis
Single cell RNaseq was performed using the Dropseq as previously described (Macosko et al., 2015). The sequencing output was
analyzed using the McCaroll lab cookbook a custom genome (mm10 plus Trinity assemblies of transgene sequences) (Grabherr
et al., 2011) and gene annotation (gencode vM14 plus). Seurat (v Seurat_2.3.4 (Butler et al., 2018) was the main platform for down-
stream analysis. Briefly DGE matrices were trimmed for quality metrics (> 100 genes, < 15% mitochondrial reads, < 1200 UMI and
genes expressed in at least 3 cells). Evaluation of potential batch effect was performed by PCA visualization in the first 3 dimensions
and outlier experiments were omitted. QC filtering resulted in expression data for 4912 cells in wild-type with a median of 813 genes
per cell and 3527 cells in OVXwith amedian of 405 genes per cell. Downstream analysis was performed according to Butler et al. with
UMI number regression and 20 principal components of variable genes being used for dimensional reduction (TSNE) and cluster call-
ing (Butler et al., 2018). We subsequently removed outlier cells that containedmore than 4,000 genes as they could potentially consti-
tute cell doublets. Analysis were performed as described previously in Valdes-Mora et al. (2019).
For comparative analysis between OVX and wild-type scRNA-seq data: Downstream analysis was performed according to Butler
et al. with UMI number regression (Butler et al., 2018). Canonical correction analysis (CCA) was performed between replicates to re-
move batch effect using the union of the top 1000 variable genes of each replicate.We removed cells where the variance explained by
CCA is less than 2-fold compared to PCA. 10 CC dimensions for wild-type and 6 for OVX were used to aligned data and dimensional
reduction (tSNE). For combined analysis wild-type cells and OVX cells were merged and 15 principal components of variable genes
were used for tSNE representation.
Statistical Analysis
All statistical analyses were performed on GraphPad Prism (v.7.02). Data are presented as mean ± s.e.m. Statistical analyses was
done using two-tailed Student’s t test, one-way ANOVA or two-way ANOVA with multiple comparisons to determine significance
in two-group and multiple-group experiments, respectively. Further details of statistical analysis and the number of mice analyzed
is included in figure legends.Cell Reports 30, 1463–1477.e1–e7, February 4, 2020 e6
DATA AND CODE AVAILABILITY
Quantitative data supporting the figures is described in the paper. The scRNA-seq data of the vaginal epithelial cells discussed in this
publication have been deposited in NCBI’s Gene Expression Omnibus (Edgar, 2002) and are accessible through GEO Series acces-
sion number GSE142212 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE142212). Additional data files will be made
available upon reasonable request from the corresponding author.e7 Cell Reports 30, 1463–1477.e1–e7, February 4, 2020
